GlaxoSmithKline says HPV vaccine worked in study

Courtesy Newsvine - business  Tue, 07/07/2009 - 11:37

Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease.


 

Related items

Prestige Brands will buy GSK brands for $660M
Prestige Brands Holdings Inc. will pay British drugmaker GlaxoSmithKline PLC $660 million cash for a group of over-the-counter pharmaceutical brands including Beano and Tagamet, its largest...

GSK receives EU approval for prostate drug
Pharmaceutical company GlaxoSmithKline PLC said Wednesday it has received European approval for Duodart, a two-in-one drug for the treatment of the symptoms of an enlarged prostate.

Notable Analyst Rating Changes 02/26: RST, AZN/GSK,...
UPGRADES Jefferies & Co upgrades Rosetta Stone (NYSE: RST) from Hold to Buy. Price target raised from $24 to $29. Goldman Sachs upgrades two pharma's from Sell to Neutral:AstraZeneca plc...

Cherry Wood Finish Adjustable Laptop Notebook...
These beautiful laptop desks are perfect for the growing use of laptops in homes. With the increase in laptop temperature, placing your laptop on your lap can become extremely uncomfortable....

Canon Pixma MX700 Office All-On-One Inkjet Printer...
With this networkable PIXMA MX700 All-In-One Office Printer, you'll be able to print photos right from compatible memory cards, selecting and enhancing images on the 1.8" color LCD display or...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com